Financials
- Market Capitalization 51.08 M
- Employee 39
- Founded 2015
- CEO Denise Scots-Knight
- Website www.mereobiopharma.com
- Headquarter United Kingdom
- FIGI BBG00KFWZC67
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-8.25
Rapporto prezzo/fatturato
121.51
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4280 | TCRT Alaunos Therapeutics, Inc. - Common Stock | 2.09 USD | 0.00% | +2.45% | -6.28% | -21.70% | 51.04 M USD | ||
| 4296 | MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.34 USD | +1.52% | +1.52% | +16.52% | -6.94% | 50.45 M USD | ||
| 4312 | ATYR aTyr Pharma, Inc. - Common Stock | 0.52 USD | +6.12% | -21.21% | +18.18% | -46.39% | 50.99 M USD | ||
| 4343 | HYPD Hyperion DeFi, Inc. - Common Stock | 3.08 USD | +4.05% | +7.32% | +3.70% | -76.31% | 46.69 M USD |